首页|期刊导航|中华医学杂志(英文版)|Recommendations for the timing,dosage,and usage of corticosteroids during cytokine release syndrome(CRS)caused by chimeric antigen receptor(CAR)-T cell therapy for hematologic malignancies
Recommendations for the timing,dosage,and usage of corticosteroids during cytokine release syndrome(CRS)caused by chimeric antigen receptor(CAR)-T cell therapy for hematologic malignancies
Sanfang Tu Xi Zhang Lugui Qiu Lei Gao Guangxun Gao Li Zhang Yimei Feng Ying Wang Mingfeng Zhao Jianqing Mi Ming Hou Xiu Luo Jianmin Yang He Huang Jianxiang Wang Yu Hu Weili Zhao Depei Wu Jun Ma Yuhua Li Wenbin Qian Xiaojun Huang Heng Mei Weidong Han Aibin Liang Yongxian Hu Yang Liu Ping Li Dehui Zou Ting Niu Kailin Xu
中华医学杂志(英文版)2024,Vol.137Issue(22):2681-2683,3.
中华医学杂志(英文版)2024,Vol.137Issue(22):2681-2683,3.DOI:10.1097/CM9.0000000000003379
Recommendations for the timing,dosage,and usage of corticosteroids during cytokine release syndrome(CRS)caused by chimeric antigen receptor(CAR)-T cell therapy for hematologic malignancies
Recommendations for the timing,dosage,and usage of corticosteroids during cytokine release syndrome(CRS)caused by chimeric antigen receptor(CAR)-T cell therapy for hematologic malignancies
摘要
引用本文复制引用
Sanfang Tu,Xi Zhang,Lugui Qiu,Lei Gao,Guangxun Gao,Li Zhang,Yimei Feng,Ying Wang,Mingfeng Zhao,Jianqing Mi,Ming Hou,Xiu Luo,Jianmin Yang,He Huang,Jianxiang Wang,Yu Hu,Weili Zhao,Depei Wu,Jun Ma,Yuhua Li,Wenbin Qian,Xiaojun Huang,Heng Mei,Weidong Han,Aibin Liang,Yongxian Hu,Yang Liu,Ping Li,Dehui Zou,Ting Niu,Kailin Xu..Recommendations for the timing,dosage,and usage of corticosteroids during cytokine release syndrome(CRS)caused by chimeric antigen receptor(CAR)-T cell therapy for hematologic malignancies[J].中华医学杂志(英文版),2024,137(22):2681-2683,3.基金项目
This work was supported by grants from the National Natural Science Foundation of China(Nos.82270233,81830004 and 82070168),National Natural Science Foundation of China Youth Science Foundation Pro-ject(No.82200246),Translational Research Grant of NCRCH(No.2020ZKZC04),National Key R&D Pro-gram of China(No.2021YFA1100800)and Shanghai Municipal Health Commission(No.2020CXJQ02). (Nos.82270233,81830004 and 82070168)